|
Income Statement for
Palomar Medical Technologies Inc.
(PMTI)
|
|
|
|
|
|
|
| Income
[+]
|
in Thousands of Dollars |
|
|
| Operating Revenue |
80,573 |
103,437 |
63,721 |
60,571 |
87,581 |
| Total Revenue |
80,573 |
103,437 |
63,721 |
60,571 |
87,581 |
| Adjustments to Revenue |
N/A |
- |
- |
- |
- |
| Cost of Revenue |
36,232 |
40,797 |
21,230 |
22,011 |
28,725 |
| Cost of Sales With Depreciation |
37,894 |
42,703 |
22,892 |
22,624 |
29,426 |
| Gross Margin |
42,679 |
62,640 |
42,491 |
38,560 |
58,856 |
| Gross Operating Profit |
42,679 |
62,640 |
42,491 |
38,560 |
58,856 |
|
| Selling/General/Admin Expense |
(38,372) |
(34,352) |
(34,563) |
(30,591) |
(43,856) |
| Research & Development |
(10,299) |
(15,644) |
(15,458) |
(14,680) |
(17,693) |
| Advertising |
- |
- |
- |
- |
- |
| EBITDA (Operating Income Before Depreciation) |
- |
12,644 |
(7,530) |
(6,711) |
(2,693) |
| Depreciation & Amortization |
(1,663) |
(1,906) |
(1,662) |
(613) |
(700) |
| Depreciation, Unreconciled |
- |
- |
- |
- |
- |
| Amortization |
- |
- |
- |
- |
- |
| Amortization of Intangibles |
- |
- |
- |
- |
- |
| Operating Income |
(6,186) |
10,738 |
(9,192) |
(7,324) |
(3,394) |
| Operating Profit After Depreciation |
(6,186) |
10,738 |
(9,192) |
(7,324) |
(3,394) |
| Interest Income |
345 |
1,096 |
422 |
760 |
3,652 |
| Earnings from Equity Interest |
- |
- |
- |
- |
- |
| Other Income, Net |
(40) |
(299) |
298 |
544 |
(317) |
| Income, Acquired in Process R&D |
- |
- |
- |
- |
- |
| Income, Restructuring and M&A |
- |
- |
- |
- |
- |
| Other Special Charges |
- |
- |
- |
- |
- |
| Total Income Before Interest Expense (EBIT) |
(5,687) |
11,534 |
(8,472) |
(6,020) |
(58) |
| Interest Expense |
N/A |
- |
- |
- |
- |
| Income Before Tax |
(5,687) |
11,534 |
(8,472) |
(6,020) |
(58) |
| Income Taxes |
(485) |
(4,106) |
(303) |
(4,439) |
(10) |
| Minority Interest |
- |
- |
- |
- |
- |
| Preferred Securities of Subsidiary Trust |
- |
- |
- |
- |
- |
| Other Special Charges |
(5,687) |
11,534 |
(8,472) |
(6,020) |
(58) |
| Net Income from Continuing Operations |
(6,171) |
7,428 |
(8,775) |
(10,459) |
(68) |
| Net Income from Discontinued Operations |
- |
- |
- |
- |
- |
| Net Income from Total Operations |
(6,171) |
7,428 |
(8,775) |
(10,459) |
(68) |
|
| Normalized Income |
(6,171) |
7,428 |
(8,775) |
(10,459) |
(68) |
| Extraordinary Income/Loss |
- |
- |
- |
- |
- |
| Special Income/Charges |
- |
- |
- |
- |
- |
| Income from Cum. Effect of Acct Change |
- |
- |
- |
- |
- |
| Income from Tax Loss Carryforward |
- |
- |
- |
- |
- |
| Net Income Available for Common |
(6,171) |
7,428 |
(8,775) |
(10,459) |
(68) |
| Other Gains |
- |
- |
- |
- |
- |
| Total Net Income |
(6,171) |
7,428 |
(8,775) |
(10,459) |
(68) |
| Net Income Available for Common |
(6,171) |
7,428 |
(8,775) |
(10,459) |
(68) |
|
| Results
[+]
|
in Dollars (Preferred Dividends in Thousands) |
|
|
| Dividends Paid Per Share |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Preferred Dividends |
- |
- |
- |
- |
- |
| Basic EPS from Continuing Operations |
-0.33 |
0.40 |
-0.47 |
-0.58 |
0.00 |
| Basic EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Extraordinary Income Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Total Net Income |
-0.33 |
0.40 |
-0.47 |
-0.58 |
0.00 |
| Basic Normalized Net Income per Share |
-0.33 |
0.40 |
-0.47 |
-0.58 |
N/A |
| Basic EPS from Total Operations |
-0.33 |
0.40 |
-0.47 |
-0.58 |
0.00 |
|
| Diluted EPS from Continuing Operations |
-0.33 |
0.39 |
-0.47 |
-0.58 |
0.00 |
| Diluted EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Extraordinary Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Total Net Income |
-0.33 |
0.39 |
-0.47 |
-0.58 |
0.00 |
| Diluted Normalized Net Income per Share |
-0.33 |
0.39 |
-0.47 |
-0.58 |
N/A |
| Excise Tax |
- |
- |
- |
- |
- |
| Diluted EPS from Total Operations |
-0.33 |
0.39 |
-0.47 |
-0.58 |
0.00 |
|
|
|
